跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XLIX
首页
药物
XLIX
XLIX
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Extraction method of gypenoside XLIX and medicine for treating diabetes and hyperlipidemia
CN 111349135 A
申请人: XU SHIMING
优先权: 2018
CN
Composition for treating coronary heart disease
CN 111166759 A
申请人: XI'AN CHIHO PHARMACEUTICAL CO LTD
优先权: 2019
CN
绞股蓝皂苷XLIX在制备用于改善肝脏脂肪代谢药物中的应用
CN 111249290 B
申请人: 山东省立医院
优先权: 2020
CN
Gynostemma pentaphylla saponin extract and preparation method thereof
CN 112159451 A
申请人: YANGLING DAILYHEALTH BIO ENGINEERING TECH CO LTD
优先权: 2020
CN
Application of gypenoside XLIX in preparation of medicine for losing weight and lowering cholesterol
CN 114366753 A
申请人: SHANDONG FIRST MEDICAL UNIV AFFILIATED PROVINCIAL HOSPITAL SHANDONG PROVINCE HOSPITAL
优先权: 2021
CN
Method for testing influence of gypenoside XLIX and gypenoside A on blood fat of rats
CN 115990274 A
申请人: SHAANXI PANLONG PHARMACEUTICAL RES INSTITUTE
优先权: 2022
CN
一种治疗失眠的皂苷组合物
CN 116327788 B
申请人: 西安巨子生物基因技术股份有限公司
优先权: 2023
CN
Method for extracting effective components of medicine for treating diabetes mellitus and hyperlipidemia
CN 118206610 A
申请人: ANKANG BEIYIDA PHARMACEUTICAL CO LTD
优先权: 2024
CN
Application of gypenoside in preparation of medicine for preventing and treating sepsis renal injury
CN 118649170 A
申请人: UNIV JIANGSU OCEAN
优先权: 2024
CN
Pharmaceutical composition and application thereof
CN 121846114 A
申请人: UNIV CAPITAL MEDICAL SCIENCES
优先权: 2026
CN
药物
反馈